Cingulate Inc. Other Non-Current Liabilities
Cingulate Inc. (CING) had Other Non-Current Liabilities of $23.61 thousand as of 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-03-28
- 2020-12-31: Other Liabilities, Noncurrent $23.61K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2020-12-31 | $23.61K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |